Senior insider sale
Chief Medical Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$570.9K
18.05K shares
What this filing means
KARLIN DANIEL plans to sell 18.05K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $570.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001950047-26-006489
Officer· Chief Medical Officer
Since Jan 2022
18.05K
Shares to sell
$570.9K
Approx. market value
10.04K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
6/25/2026
10.04KTotal acquired10.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 10.04K | — |
| Total | 10.04K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
8.02K
Market value
$148.1K
3/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.04K
Market value
$422.8K
6/25/2026
Total
Units
18.05K
Value
$570.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/25/2026 | 8.02K | $148.1K | — | Completed |
| Planned — Approximate Date | ||||
6/25/2026 | 10.04K | $422.8K | NASDAQ | Planned |
| Total | 18.05K | $570.9K | ||